MedTech Europe, BVMed, which is the German Medical Technology Organisation, and the Association of British HealthTech Industries (ABHI) had all called for a delay to the reforms.
MedTech Europe said that helping healthcare systems to overcome the coronavirus outbreak "is and will be in everyone’s top priority and focus". It said: "Manufacturers are striving to keep needed medical technologies available to healthcare systems while managing the effects of the pandemic on their organisations. This severely disrupts healthcare stakeholders’ efforts to implement the [new regulations] within the fixed transition timelines."
Life sciences expert Tamsin Cornwell of Pinsent Masons, the law firm behind Out-Law, said: "The Covid-19 pandemic has, understandably, diverted resources that would otherwise have been focussed on preparing for implementation of the reforms. The necessary response to the Covid-19 pandemic, including travel restrictions, isolation and social distancing, has, and will continue to, hinder work necessary for companies to prepare. Therefore a delay to implementation should assist various parties, not least healthcare providers dealing directly with the Covid-19 pandemic."
Cornwell said: "A delay to implementation to 2021 would be after the Brexit transition period expires. This would mean the MDR and IVDR would never be in force in the UK. The UK government will need to decide whether to adopt UK legislation identical to the MDR and IVDR or have divergent legislation in some form."
Plans to supplement the MDR and IVDR with additional reforms to medical device regulations in Germany were outlined last year.